Showing results (811-820 of 816) with videos related to
Sort By:
Pageof 82
You have reached the last page of results.This site can display upto 816 results.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|February 1, 2023
[Guideline for clinical comprehensive evaluation of Chinese patent medicine (2022 version)]Wei-An Yuan, Jun-Hua Zhang, Jian-Ping Liu, et al.Journal of Medicinal Chemistry|October 30, 2013
Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonistJennifer X Qiao, Tammy C Wang, Réjean Ruel, et al.Journal of Medicinal Chemistry|June 22, 2022
Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4E Scott Priestley, Jacques Banville, Daniel Deon, et al.Bioorganic & Medicinal Chemistry Letters|February 12, 2014
Identification of 1-{2-[4-chloro-1'-(2,2-dimethylpropyl)-7-hydroxy-1,2-dihydrospiro[indole-3,4'-piperidine]-1-yl]phenyl}-3-{5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl}urea, a potent, efficacious and orally bioavailable P2Y(1) antagonist as an antiplatelet agentYoon T Jeon, Wu Yang, Jennifer X Qiao, et al.The Journal of Infectious Diseases|May 9, 2020
A Peptide-Based Magnetic Chemiluminescence Enzyme Immunoassay for Serological Diagnosis of Coronavirus Disease 2019Xue-Fei Cai, Juan Chen, Jie- Li Hu, et al.Nature Medicine|May 1, 2020
Antibody responses to SARS-CoV-2 in patients with COVID-19Quan-Xin Long, Bai-Zhong Liu, Hai-Jun Deng, et al.Pageof 82